BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7887647)

  • 21. Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review.
    Shimada N; Ohno N; Tanosaki R; Fuji S; Suzuki Y; Yuji K; Uchimaru K; Tojo A
    Intern Med; 2017; 56(14):1879-1884. PubMed ID: 28717086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spontaneous remission in adult T-cell leukemia].
    Kikuchi M; Ono K; Shimamoto Y; Yamaguchi M
    Rinsho Ketsueki; 1993 Jun; 34(6):728-32. PubMed ID: 8366575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases.
    Bittencourt AL; Barbosa HS; Vieira MD; Farré L
    Acta Oncol; 2009; 48(4):598-604. PubMed ID: 19165640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma.
    Matsushita K; Matsumoto T; Ohtsubo H; Fujiwara H; Imamura N; Hidaka S; Kukita T; Tei C; Matsumoto M; Arima N
    Leuk Lymphoma; 1999 Dec; 36(1-2):67-75. PubMed ID: 10613451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of post-mogamulizumab relapse of acute-type adult T-cell leukemia/lymphoma successfully treated with mogamulizumab and etoposide.
    Sekiguchi Y; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Kinoshita A; Suga Y; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(9):6278-90. PubMed ID: 25337281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].
    Tsukaguchi M; Furukawa Y; Shibano M; Kitani T
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of gastric malignant lymphoma markedly responding to chronic daily and oral administration of low-dose etoposide].
    Moriya A; Ikeda A; Yokoyama N; Yokoyama T; Abe Y; Miyamoto K
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2229-33. PubMed ID: 8239691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
    Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successful treatment with etoposide by oral administration for recurrence of gastric diffuse large B-cell lymphoma after surgical resection--a case report].
    Fukushima T; Sawaki T; Shimoyama K; Karasawa H; Masaki Y; Kawabata H; Ogawa N; Wano Y; Hirose Y; Sugai S; Sutoh H; Itoh H; Kojima Y
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):251-3. PubMed ID: 15751644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
    Yoshida T; Takagi T; Shimoyama M; Mikuni C; Suzuki K; Egami K; Furusawa S; Nomura T; Mori M; Sugimoto T
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2793-801. PubMed ID: 7993116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.
    Cohen MH; Johnson JR; Justice R; Pazdur R
    Oncologist; 2008 Jun; 13(6):709-14. PubMed ID: 18586926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
    Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
    Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intracranial and orbital extension of a nasal cavity adult T-cell leukemia: a case report].
    Hayashi K; Anda T; Yasunaga A; Shibata S; Sadamori N; Kisikawa M; Tsuda N
    No Shinkei Geka; 1999 Jan; 27(1):55-9. PubMed ID: 10024985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
    Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
    Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
    Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
    Wadhwa PD; Fu P; Koc ON; Cooper BW; Fox RM; Creger RJ; Bajor DL; Bedi T; Laughlin MJ; Payne J; Gerson SL; Lazarus HM
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):13-22. PubMed ID: 15625540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cyclosporin A withdrawal causes spontaneous remission of recurrent subcutaneous tumors after allogeneic peripheral blood stem cell transplantation for adult T-cell leukemia/lymphoma].
    Ohguchi H; Sai T; Hamazaki Y; Hiwatashi K
    Rinsho Ketsueki; 2003 Feb; 44(2):102-7. PubMed ID: 12692982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral antitumor drugs for hematological malignancies].
    Ohnishi K
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):295-300. PubMed ID: 10065091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.